143 related articles for article (PubMed ID: 7480547)
1. The stimulation of cholecystokinin receptors in the rostral nucleus accumbens significantly antagonizes the EEG and behavioural effects induced by phencyclidine in rats.
Popoli P; Reggio R; Pèzzola A; Scotti de Carolis A
Psychopharmacology (Berl); 1995 Jul; 120(2):156-61. PubMed ID: 7480547
[TBL] [Abstract][Full Text] [Related]
2. PD-135158, a CCKB receptor antagonist, microinjected into the nucleus accumbens and the expression of conditioned rewarded behavior.
Josselyn SA; Franco VP; Vaccarino FJ
Neurosci Lett; 1996 May; 209(2):85-8. PubMed ID: 8761988
[TBL] [Abstract][Full Text] [Related]
3. Behavioral and cortical EEG evaluations confirm the roles of both CCKA and CCKB receptors in mouse CCK-induced anxiety.
Li H; Ohta H; Izumi H; Matsuda Y; Seki M; Toda T; Akiyama M; Matsushima Y; Goto Y; Kaga M; Inagaki M
Behav Brain Res; 2013 Jan; 237():325-32. PubMed ID: 23043971
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in nucleus accumbens of the rat via the CCK-B receptor.
Pu SF; Zhuang HX; Han JS
Brain Res; 1994 Sep; 657(1-2):159-64. PubMed ID: 7820614
[TBL] [Abstract][Full Text] [Related]
5. CCK-B receptors in the limbic system modulate the antidepressant-like effects induced by endogenous enkephalins.
Smadja C; Ruiz F; Coric P; Fournié-Zaluski MC; Roques BP; Maldonado R
Psychopharmacology (Berl); 1997 Aug; 132(3):227-36. PubMed ID: 9292622
[TBL] [Abstract][Full Text] [Related]
6. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
Singh L; Field MJ; Hughes J; Menzies R; Oles RJ; Vass CA; Woodruff GN
Br J Pharmacol; 1991 Sep; 104(1):239-45. PubMed ID: 1686205
[TBL] [Abstract][Full Text] [Related]
7. Different capability of N-methyl-D-aspartate antagonists to elicit EEG and behavioural phencyclidine-like effects in rats.
Sagratella S; Pezzola A; Popoli P; Scotti de Carolis AS
Psychopharmacology (Berl); 1992; 109(3):277-82. PubMed ID: 1365627
[TBL] [Abstract][Full Text] [Related]
8. Role of cholecystokinin-A and cholecystokinin-B receptors in anxiety.
Hernandez-Gómez AM; Aguilar-Roblero R; Pérez de la Mora M
Amino Acids; 2002; 23(1-3):283-90. PubMed ID: 12373548
[TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin (CCK) increases GABA release in the rat anterior nucleus accumbens via CCK(B) receptors located on glutamatergic interneurons.
Lanza M; Makovec F
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):33-8. PubMed ID: 10651144
[TBL] [Abstract][Full Text] [Related]
10. Relationship between vulnerability to reinforcing effects of morphine and activity of the endogenous cholecystokinin system in Lewis and Fischer rats.
Noble F; Benturquia N; Crete D; Canestrelli C; Mas Nieto M; Wilson J; Roques BP
Addict Biol; 2012 May; 17(3):528-38. PubMed ID: 21309946
[TBL] [Abstract][Full Text] [Related]
11. Mediation by CCKB receptors of the CCK-evoked hyperaemia in rat gastric mucosa.
Heinemann A; Jocic M; Holzer-Petsche U; Pethö G; Peskar BM; Horwell DC; Holzer P
Br J Pharmacol; 1995 Oct; 116(4):2274-8. PubMed ID: 8564259
[TBL] [Abstract][Full Text] [Related]
12. Selective agonists of metabotropic glutamate receptors elicit significant EEG effects when infused in the nucleus accumbens of rats.
Popoli P; Pèzzola A; Reggio R; Tiburzi F
Eur J Pharmacol; 1999 Feb; 367(2-3):183-8. PubMed ID: 10078991
[TBL] [Abstract][Full Text] [Related]
13. Dual modulation of dopamine release from anterior nucleus accumbens through cholecystokinin-B receptor subsites.
Léna I; Roques BP; Durieux C
J Neurochem; 1997 Jan; 68(1):162-8. PubMed ID: 8978722
[TBL] [Abstract][Full Text] [Related]
14. Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies.
Hutson PH; Barton CL; Jay M; Blurton P; Burkamp F; Clarkson R; Bristow LJ
Neuropharmacology; 2000 Sep; 39(12):2318-28. PubMed ID: 10974315
[TBL] [Abstract][Full Text] [Related]
15. Activation of amygdala cholecystokininB receptors potentiates the acoustic startle response in the rat.
Frankland PW; Josselyn SA; Bradwejn J; Vaccarino FJ; Yeomans JS
J Neurosci; 1997 Mar; 17(5):1838-47. PubMed ID: 9030642
[TBL] [Abstract][Full Text] [Related]
16. [Study of induced effects by selective CCKB agonists cholecystokinin in the nociception and behavior in rodents].
Dauge V; Derrien M; Durieux C; Noble F; Corringer PJ; Roques BP
Therapie; 1992 Nov; 47(6):531-9. PubMed ID: 1301645
[TBL] [Abstract][Full Text] [Related]
17. PD 135158, a CCKB/gastrin receptor antagonist, stimulates rat pancreatic enzyme secretion as a CCKA receptor agonist.
Höcker M; Hughes J; Fölsch UR; Schmidt WE
Eur J Pharmacol; 1993 Sep; 242(1):105-8. PubMed ID: 7901038
[TBL] [Abstract][Full Text] [Related]
18. Anxiolytic effects of CCK-B antagonists.
Costall B; Domeney AM; Hughes J; Kelly ME; Naylor RJ; Woodruff GN
Neuropeptides; 1991 Jul; 19 Suppl():65-73. PubMed ID: 1679211
[TBL] [Abstract][Full Text] [Related]
19. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.
Singh L; Lewis AS; Field MJ; Hughes J; Woodruff GN
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1130-3. PubMed ID: 1996314
[TBL] [Abstract][Full Text] [Related]
20. Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray.
Netto CF; Guimarães FS
Neuropsychopharmacology; 2004 Jan; 29(1):101-7. PubMed ID: 14583742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
